Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT05502133
Identification of Acute Intermittent Porphyria Modifying Genes
Sponsor: Icahn School of Medicine at Mount Sinai
View on ClinicalTrials.gov
Summary
This study proposes to identify the predisposing/protective modifying genes that underlie the acute attacks in symptomatic patients with Acute Intermittent Porphyria (AIP), an autosomal dominant inborn error of heme biosynthesis.
Key Details
Gender
All
Age Range
12 Years - Any
Study Type
OBSERVATIONAL
Enrollment
150
Start Date
2022-09-23
Completion Date
2026-06
Last Updated
2025-08-28
Healthy Volunteers
No
Conditions
Locations (1)
Icahn School of Medicine at Mount Sinai
New York, New York, United States